Cosmo Bio Co (TSE:3386) OCF Margin %: -1.85% (As of Dec. 2025)


TSE:3386 Cosmo Bio Co Ltd TSE:3386
71 GF Score
Price 円1,235.00
GF Value 円1,244.50
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cosmo Bio Co OCF Margin %?

Cosmo Bio Co TSE:3386 -0.32% 71 OCF Margin % is -1.85% as of Dec. 2025. GuruFocus rates TSE:3386 with a GF Score™ of 71/100 and a GF Value™ of 円1,244.50 (Fairly Valued). The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Cosmo Bio Co ranks better than 50.49% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Cosmo Bio Co's Cash Flow from Operations for the six months ended in Dec. 2025 was 円-99 Mil. Cosmo Bio Co's Revenue for the six months ended in Dec. 2025 was 円5,364 Mil. Therefore, Cosmo Bio Co's OCF Margin % for the quarter that ended in Dec. 2025 was -1.85%.

As of today, Cosmo Bio Co's current OCF Yield % is 8.52%.

The historical rank and industry rank for Cosmo Bio Co's OCF Margin % or its related term are showing as below:

TSE:3386' s OCF Margin % Range Over the Past 10 Years
Min: 1.26   Med: 7.13   Max: 12.51
Current: 5.53


During the past 13 years, the highest OCF Margin % of Cosmo Bio Co was 12.51%. The lowest was 1.26%. And the median was 7.13%.

TSE:3386's OCF Margin % is ranked better than
50.49% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755 vs TSE:3386: 5.53


Cosmo Bio Co OCF Margin % Related Terms


Cosmo Bio Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for Cosmo Bio Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Bio Co OCF Margin % Chart

Cosmo Bio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.02 2.97 7.88 2.40 5.53

Cosmo Bio Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.48 6.04 -1.41 12.85 -1.85

TSE:3386 vs TMO, DHR, IDXX: OCF Margin % Comparison

For the Diagnostics & Research subindustry, Cosmo Bio Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmo Bio Co OCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cosmo Bio Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Cosmo Bio Co's OCF Margin % falls into.


TSE:3386
71GF Score
Cosmo Bio Co Ltd TSE:3386
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmo Bio Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Cosmo Bio Co's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=595/10766
=5.53 %

Cosmo Bio Co's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-99/5364
=-1.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -1.85% mean?
Cosmo Bio Co (TSE:3386) has a OCF Margin % of -1.85% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cosmo Bio Co and its competitors. Over the past decade, Cosmo Bio Co's OCF Margin % has ranged from 1.26 to 12.51. According to the industry distribution chart, Cosmo Bio Co ranks #101 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 49.5%.
Is Cosmo Bio Co's OCF Margin % too high?
Cosmo Bio Co's current OCF Margin % is -1.85%. Over the past 10 years, this metric has ranged from a low of 1.26 to a high of 12.51. Based on the distribution chart, Cosmo Bio Co ranks #101 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Cosmo Bio Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cosmo Bio Co's OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Cosmo Bio Co ranks #101 out of 204 companies for OCF Margin %. This puts Cosmo Bio Co in the upper half of its industry. The industry median OCF Margin % is 4.76. Historically, Cosmo Bio Co's own OCF Margin % has ranged from 1.26 to 12.51 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cosmo Bio Co and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmo Bio Co's current OCF Margin % is -1.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo Bio Co stock overvalued right now?
Based on GuruFocus' analysis, Cosmo Bio Co (TSE:3386) is currently considered Fairly Valued. The stock's GF Value™ is 円1,244.50, compared to a current price of 円1,235.00 — trading 0.8% below its estimated fair value. The current OCF Margin % is -1.85%. Cosmo Bio Co's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cosmo Bio Co (TSE:3386), the current OCF Margin % is -1.85% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo Bio Co (TSE:3386) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo Bio Co stock appears to be undervalued. The current stock price of 円1,235.00 is trading 0.8% below its estimated GF Value™ of 円1,244.50. GuruFocus considers Cosmo Bio Co to be Fairly Valued.

Key valuation signals for TSE:3386:

  • OCF Margin %: -1.85%
  • GF Value™: 円1,244.50 vs. price of 円1,235.00 (0.8% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the TSE:3386 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cosmo Bio Co Business Description

Address 2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes the purchase of reagents, instruments, and clinical test drugs for research in life science and domestic sales.
71GF Score

Get the complete analysis for TSE:3386

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,235.00
Price
円1,244.50
GF Value